Effects of Panax ginseng in Neurodegenerative Diseases

被引:178
作者
Cho, Ik-Hyun [1 ,2 ]
机构
[1] Kyung Hee Univ, Coll Oriental Med, Dept Anat, Seoul 130701, South Korea
[2] Kyung Hee Univ, Inst Oriental Med, Seoul 130701, South Korea
基金
新加坡国家研究基金会;
关键词
Panax ginseng; Ginsenosides; Neuroprotection; Neurodegeneration; MULTIPLE-SCLEROSIS; PC12; CELLS; ANTIINFLAMMATORY MECHANISM; MICROGLIAL ACTIVATION; ACIDIC POLYSACCHARIDE; COGNITIVE PERFORMANCE; INDUCED NEUROTOXICITY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; INDUCED APOPTOSIS;
D O I
10.5142/jgr.2012.36.4.342
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Ginseng, the root of the Panax ginseng, has been a popular and widely-used traditional herbal medicine in Korea, China, and Japan for thousands of years. Now it has become popular as a functional health food and is used globally as a natural medicine. Evidence is accumulating in the literature on the physiological and pharmacological effects of P ginseng on neurodegenerative diseases. Possible ginseng- or ginsenosides-mediated neuroprotective mechanisms mainly involve maintaining homeostasis, and anti-inflammatory, anti-oxidant, anti-apoptotic, and immune-stimulatory activities. This review considers publications dealing with the various actions of P ginseng that are indicative of possible neurotherapeutic efficacies in neurodegenerative diseases and neurological disorders such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis and multiple sclerosis.
引用
收藏
页码:342 / 353
页数:12
相关论文
共 98 条
[1]
Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[2]
NATURAL PRODUCT DRUG DISCOVERY AND DEVELOPMENT - NEW PERSPECTIVES ON INTERNATIONAL COLLABORATION [J].
BAKER, JT ;
BORRIS, RP ;
CARTE, B ;
CORDELL, GA ;
SOEJARTO, DD ;
CRAGG, GM ;
GUPTA, MP ;
IWU, MM ;
MADULID, DR ;
TYLER, VE .
JOURNAL OF NATURAL PRODUCTS, 1995, 58 (09) :1325-1357
[3]
Hypoxia signaling to genes - Significance in Alzheimer's disease [J].
Bazan, NG ;
Palacios-Pelaez, R ;
Lukiw, WJ .
MOLECULAR NEUROBIOLOGY, 2002, 26 (2-3) :283-298
[4]
BEAL MF, 1993, J NEUROSCI, V13, P4181
[5]
Onset and progression in inherited ALS determined by motor neurons and microglia [J].
Boillee, Severine ;
Yamanaka, Koji ;
Lobsiger, Christian S. ;
Copeland, Neal G. ;
Jenkins, Nancy A. ;
Kassiotis, George ;
Kollias, George ;
Cleveland, Don W. .
SCIENCE, 2006, 312 (5778) :1389-1392
[6]
3-nitropropionic acid animal model and Huntington's disease [J].
Borlongan, CV ;
Koutouzis, TK ;
Sanberg, PR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (03) :289-293
[7]
Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[8]
Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium [J].
Chen, Chieh-fu ;
Chiou, Wen-fei ;
Zhang, Jun-tian .
ACTA PHARMACOLOGICA SINICA, 2008, 29 (09) :1103-1108
[9]
Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides [J].
Chen, Feng ;
Eckman, Elizabeth A. ;
Eckman, Christopher B. .
FASEB JOURNAL, 2006, 20 (08) :1269-+
[10]
Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress [J].
Chen, XC ;
Zhou, YC ;
Chen, Y ;
Zhu, YG ;
Fang, F ;
Chen, LM .
ACTA PHARMACOLOGICA SINICA, 2005, 26 (01) :56-62